Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Manage my Boston Scientific account

Quick Links

Contact a representative
Online education and training
Order products online
Reimbursement resources
Return a product
Customer support

Call customer care

1 (888) 272-1001

Employee in a corporate workplace, highlighting professional growth and employee engagement.

innovative care

Access and equity

We are dedicated to reducing health disparities and expanding access to care worldwide, regardless of socioeconomic status, geography or background.

Expanding market access through evidence

Our Health Economics and Market Access (HEMA) and Health Economics and Outcomes Research (HEOR) teams use economic, clinical and real-world evidence to generate evidence that demonstrates the value of our therapies.

  • We generate and publish peer-reviewed health economic research to strengthen the evidence available to payers and healthcare decision-makers worldwide.
  • We engage with global payers and health technology assessment (HTA) organizations to inform decisions about the adoption and funding of innovative medical technologies.
  • Through participation in international policy forums such as Health Technology Assessment International (HTAi), we collaborate with global stakeholders and help advance understanding of the value of MedTech. In 2025, we hosted the Asia Policy Forum delegation at our Penang facility, the first HTA visit to an industry site, helping shape how payers and HTA agencies across Asia evaluate medical technologies.

Recent publications for advancing value-based care:

Catheter ablation of atrial fibrillation followed by left atrial appendage closure: A retrospective analysis of adverse events occurring between procedures, Value in Health.
Medicare Cost Comparison of Transcarotid Artery Revascularization (TCAR) Versus Transfemoral Carotid Artery Stenting (TF-CAS), Value in Health.
Comparing pulsed field ablation and thermal energy catheter ablation for paroxysmal atrial fibrillation: a cost-effectiveness analysis of the ADVENT trial, Journal of Medical Economics.

Expanding access to care for underserved patients

We work to improve access to care for communities facing systemic barriers.

For more than two decades, our Close the Gap (CTG) initiative has focused on expanding access to care for underserved patients. Through initiatives like CTG, we are identifying patients at risk of missing treatment, increasing diversity in clinical trials and equipping providers with targeted education — advancing science that improves outcomes while expanding access to life-changing therapies.

Read more about Close the Gap
  1. Represents GAAP R&D expense per Annual Report on Form 10-K.
  2. Represents GAAP R&D expense as a percentage of GAAP net sales per Annual Report on Form 10-K.